The gene-therapy revolution risks stalling if we don't talk about drug pricing.
Nature, 616(7958): 629-630 PMID 37100946 DOI 10.1038/d41586-023-01389-z
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.